Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia

Published:2015-03-04 Issue:2 Volume:7 Page:390-402
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Fitting Jenny,Blume Tobias,ten Haaf Andre,Blau Wolfgang,Gattenlöhner Stefan,Tur Mehmet Kemal,Barth Stefan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1007818

Reference38 articles.

1. Monoclonal Antibodies for the Treatment of Acute Myeloid Leukemia

2. American Cancer Society Cancer Facts & Figures 2013. Atlanta: American Cancer Society, 2013. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf

3. The Difficult Problem of Acute Myeloid Leukemia in the Older Adult

4. Antibody Therapy for Acute Myeloid Leukemia

5. Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage display for discovery of anticancer antibodies;New Biotechnology;2024-11

2. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18

3. Development of a new affinity maturation protocol for the construction of an internalizing anti-nucleolin antibody library;Scientific Reports;2024-05-08

4. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate;Journal of Cancer Research and Clinical Oncology;2023-07-11

5. Construction and evaluation of GPC3-targeted immunotoxins as a novel therapeutic modality for hepatocellular carcinoma;International Immunopharmacology;2022-12